Managing Myeloma
- 2010-06-03 - Data at ASCO Show Promise of Novartis Drugs For Patients With Life-Threatening Diseases Like CML, Multiple Myeloma and Breast Cancer
- 2010-06-03 - NEWS FLASH:NICE Backs First-line Use of JNJ's Bortezomib, Also Supports Use of Celgene's Thalidomide In Multiple Myeloma
- 2010-06-01 - ASCO Releases Studies From Upcoming Annual Meeting
- 2010-06-01 - NEWS FLASH:Multiple Myeloma Research Consortium (MMRC) Announces Data Presentations at 46th Annual American Society of Clinical Oncology (ASCO) Annual Meeting
- 2010-05-28 - Myeloma Research To Be Presented At The American Society of Clinical Oncology’s 46th Annual Meeting (ASCO 2010)
- 2010-05-27 - Millennium Announces Bortezomib Presentations and First Data in Solid Tumors for Pipeline Molecules at American Society of Clinical Oncology Annual Meeting
- 2010-05-27 - Celgene says Barr withdrew generic thalidomide filing
- 2010-05-27 - Pat’s Place: How Do You Know Which Therapy Is Right For You?
- 2010-05-26 - Maintenance with lenalidomide extended PFS after ASCT for multiple myeloma
- 2010-05-24 - African-Americans and women are less likely to undergo bone marrow transplantation-Public Release: Medical College of Wisconsin
- 2010-05-24 - Cancer cuts teacher's career short
- 2010-05-24 - ASCO: Thalidomide Analogue Cuts Myeloma Relapses
- 2010-05-23 - Fight off multiple Myeloma like Lisa-Deccan Chronicle
- 2010-05-21 - Special Report: J. Craig Venter Institute creates first synthetic life form
- 2010-05-21 - Celgene's lenalidomide positive data reported in maintenance trials